Edwards Lifesciences Acquires CardioVations Product Line

 

December 27, 2007

December 21, 2007 - Edwards Lifesciences Corp. (Edwards) has completed its acquisition of certain assets of the CardioVations Division of Ethicon, Inc., a product line that is expected to give Edwards surgical partners new avenues to optimize patient outcomes.

The CardioVations product line includes the PORT-ACCESS products for performing minimally invasive cardiac valve procedures. The line is expected to generate sales of more than $20 million in 2008. It is not expected to have an impact on earnings in 2008 and will be accretive thereafter.

For more information: www.edwards.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.